111 related articles for article (PubMed ID: 10805224)
1. Liposome-mediated transfer of IL-1 receptor antagonist gene to dispersed islet cells does not prevent recurrence of disease in syngeneically transplanted NOD mice.
Saldeen J; Sandler S; Bendtzen K; Welsh N
Cytokine; 2000 Apr; 12(4):405-8. PubMed ID: 10805224
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor antagonist enhances islet engraftment without impacting serum levels of nitrite or osteopontin.
Hsu BR; Fu SH; Hsu S; Chen ST
Transplant Proc; 2009 Jun; 41(5):1781-5. PubMed ID: 19545727
[TBL] [Abstract][Full Text] [Related]
3. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
[TBL] [Abstract][Full Text] [Related]
5. Expression of an insulin/interleukin-1 receptor antagonist hybrid gene in insulin-producing cell lines (HIT-T15 and NIT-1) confers resistance against interleukin-1-induced nitric oxide production.
Welsh N; Bendtzen K; Welsh M
J Clin Invest; 1995 Apr; 95(4):1717-22. PubMed ID: 7706480
[TBL] [Abstract][Full Text] [Related]
6. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
[TBL] [Abstract][Full Text] [Related]
7. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice.
Yasuda H; Nagata M; Arisawa K; Yoshida R; Fujihira K; Okamoto N; Moriyama H; Miki M; Saito I; Hamada H; Yokono K; Kasuga M
J Clin Invest; 1998 Nov; 102(10):1807-14. PubMed ID: 9819366
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1beta and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation.
Montolio M; Biarnés M; Téllez N; Escoriza J; Soler J; Montanya E
J Endocrinol; 2007 Jan; 192(1):169-77. PubMed ID: 17210754
[TBL] [Abstract][Full Text] [Related]
9. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.
Westwell-Roper C; Dai DL; Soukhatcheva G; Potter KJ; van Rooijen N; Ehses JA; Verchere CB
J Immunol; 2011 Sep; 187(5):2755-65. PubMed ID: 21813778
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
[TBL] [Abstract][Full Text] [Related]
11. Gene combination transfer to block autoimmune damage in transplanted islets of Langerhans.
Bertera S; Alexander AM; Crawford ML; Papworth G; Watkins SC; Robbins PD; Trucco M
Exp Diabesity Res; 2004; 5(3):201-10. PubMed ID: 15512788
[TBL] [Abstract][Full Text] [Related]
12. Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules.
Sakata M; Yasuda H; Moriyama H; Yamada K; Kotani R; Kurohara M; Okumachi Y; Kishi M; Arai T; Hara K; Hamada H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2008 Jun; 80(3):352-9. PubMed ID: 18400329
[TBL] [Abstract][Full Text] [Related]
13. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
[TBL] [Abstract][Full Text] [Related]
14. Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets.
Maedler K; Sergeev P; Ehses JA; Mathe Z; Bosco D; Berney T; Dayer JM; Reinecke M; Halban PA; Donath MY
Proc Natl Acad Sci U S A; 2004 May; 101(21):8138-43. PubMed ID: 15141093
[TBL] [Abstract][Full Text] [Related]
15. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
Cheng J; Sun J; Sung RS
Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis.
Yang SY; Wu B; Mayton L; Mukherjee P; Robbins PD; Evans CH; Wooley PH
Gene Ther; 2004 Mar; 11(5):483-91. PubMed ID: 14724688
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist.
Yang GY; Liu XH; Kadoya C; Zhao YJ; Mao Y; Davidson BL; Betz AL
J Cereb Blood Flow Metab; 1998 Aug; 18(8):840-7. PubMed ID: 9701345
[TBL] [Abstract][Full Text] [Related]
18. Electrotransfer of human IL-1Ra into skeletal muscles reduces the incidence of murine collagen-induced arthritis.
Jeong JG; Kim JM; Ho SH; Hahn W; Yu SS; Kim S
J Gene Med; 2004 Oct; 6(10):1125-33. PubMed ID: 15452879
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
Jiang TJ; Zhou ZG; Su H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
[TBL] [Abstract][Full Text] [Related]
20. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
